AF
ORIC icon

Allworth Financial’s Oric Pharmaceuticals ORIC Stock Holding History

Allworth Financial’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.77K Buy
+140
New +$1.59K ﹤0.01% 4381
2025
Q4 		– Sell
-2
Closed -$24 – 5212
2025
Q3 		$24 Hold
2
– – ﹤0.01% 4810
2025
Q2 		$21 Buy
+2
New +$13 ﹤0.01% 4516

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Allworth Financial's ORIC Position: Q1 2026 in Review

Allworth Financial opened a new position in Oric Pharmaceuticals (ORIC) in Q1 2026: 140 shares worth $1.77K. The stake represents ﹤0.01% of the portfolio and ranks #4381 among its holdings. This is a return to the name: Allworth Financial previously reported a position in ORIC as recently as Q3 2025.

Allworth Financial first reported a position in ORIC in Q2 2025 and has held it in 3 quarters since. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

  • Allworth Financial held 140 shares of Oric Pharmaceuticals worth $1.77K as of Q1 2026.
  • Oric Pharmaceuticals was a new Allworth Financial position in Q1 2026.
  • Oric Pharmaceuticals made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #4381 holding.
  • Allworth Financial first reported a position in Oric Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • 182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.